Ursodeoxycholic acid use is associated with significant risk of morbidity and mortality in infants with cholestasis: A strobe compliant study

The off-label use of medications is a “right” for pediatricians, owing to lack of enough safety and effectiveness drug trials in pediatric age group. Pediatricians have to rely on their personal judicial use of medications in children. We studied off-label use of ursodeoxycholic acid (UDCA) retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotb, Magd Ahmed, Mosallam, Dalia, Basanti, Christine William Shaker, El Sorogy, Sally Talaat Mostafa, Badr, Ahmed M., Abd El Baky, Hend El Hosainy, Draz, Iman Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035015/
https://www.ncbi.nlm.nih.gov/pubmed/32049781
http://dx.doi.org/10.1097/MD.0000000000018730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035015/
https://www.ncbi.nlm.nih.gov/pubmed/32049781
http://dx.doi.org/10.1097/MD.0000000000018730

Ejemplares similares